Navigation Links
RSV ASR

ProductsRSV ASR
Company Cepheid
Item RSV ASR
Features 
Description The RSV ASR contains primers and a FAM-labeled probe that is designed to detect Respiratory Syncytial Virus (RSV). In addition, this ASR contains primers and a Texas Red-labeled probe for a separate sample processing control. This ASR requires an instrument that can detect FAM and Texas Red reporter dyes such as the Cepheid SmartCycler System.

The Cepheid Analyte Specific Reagent* (ASR) program is comprised of a series of easy-to-use primer and probe sets in a convenient lyophilized bead format. Every ASR product is manufactured under cGMP for maximum product consistency and quality. Cepheid ASRs are also delivered with an internal control** to ensure optimum reliability by confirming that negatives are truly negative not inhibited. Each ASR product is designed for rapid results on real-time PCR instruments like the Cepheid SmartCycler System.

* Analytical and performance characteristics are not established. ASRs can only be sold to clinical laboratories regulated under the CLIA of 1988, as qualified to perform high complexity testing under 42 CFR part 493 or under VHA directive 1106.
** See specific ASR product datasheet for internal control information.

Info Cepheid
Customer Service: (408) 541-4191
Web site: http://www.cepheid.com/

Related medicine products :

1. KOWA nonmyd 7 / VK-2 Digital Imaging System
2. Projection Digital Lensmeter LM-770
3. KOWA nonmyd a-D / VK-2 Digital Imaging System
4. Coolscope Digital Microscope
5. MIC-D Digital Microscope
6. Airfuge Ultracentrifuge - For 60 Hz, 120V; with Digital Tachometer
7. Quebec Darkfield Digital Colony Counter, 110V with USA Cord
8. Quebec Darkfield Digital Colony Counter, 220V with EU Cord
9. DS-5M-L1 Digital Sight Camera System
10. Magnafire SP Digital Camera
11. ODEI75D Digital / Video Camera
Conventional Digitally-Controlled Water Baths...
... The Dengue virus belongs to the Flavavirus ... commonly throughout the tropics.,Symptoms of Dengue fever ... pain in the back and limbs, lymphadenopathy,maculopapular ... for professional use as an aid in ...
... test is a rapid, qualitative test ... T. cruzi in human serum or ... test is intended primarily as an ... should be confirmed by a supplemental ...
... test is a qualitative one step ... conation of monoclonal,antibody/colloidal gold dye conjugate ... the solid phase. This will selectively ... (typhoid) infection with a high degree ...
Medicine Products:
(Date:3/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce ... director. Mr. Still was selected through a careful months-long search by the RBMA Board ... to our members, has been a part of building the RBMA since 1992,” said ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... release of two biometric time and attendance tracking products: the new NCheck Cloud ... NCheck Cloud Bio Attendance uses biometric face recognition to enable users to check ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Executives, Staff & Clients ... to for the Toys for Tots Literacy Campaign at their Semi-Annual Graduation and Fundraiser ... $70 billion, the U.S. ranks at number 14 internationally in literacy. Statistically, a direct ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... SkyLex Advanced Surgical, Inc. is thrilled to offer the recently FDA-approved Obalon Balloon ... this procedure adds to SkyLex Advanced Surgical’s already comprehensive list of weight-loss ...
(Date:3/28/2017)... , ... March 28, 2017 , ... Silicon Valley Hair ... to announce a new blog post about women’s hair loss. Although hair transplant procedures ... loss as they age. Menopause or genetics can be two reasons a woman may ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... REDWOOD CITY, Calif. , March 28, 2017 ... pharmaceutical company focused on the development and commercialization ... acute pain, announced that the European Medicines Agency ... (sufentanil sublingual tablet, 30 mcg) Marketing Authorisation Application ... review of the MAA is underway. The MAA ...
(Date:3/28/2017)... 28, 2017 RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Japan Patent Office (JPO) for the composition of ... (CTGF) for the treatment or prevention of fibrotic ... and proliferative retinopathy (Japanese Patent #: 6060071).  This ...
(Date:3/28/2017)... , March 28, 2017 ... to reach USD 8.0 billion by 2025, according to ... increasing incidence of infectious diseases and cancer is expected ... in disease diagnosis over the coming years. In addition, ... of autologous and allogenic stem cell therapy, due to ...
Breaking Medicine Technology: